Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Factors affecting drug concentrations and QT interval during thioridazine therapy.

Factors affecting drug concentrations and QT interval during thioridazine therapy. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Factors affecting drug concentrations and QT interval during thioridazine therapy. Abstract Text:

    r h k thanacoodyR H K Thanacoody,a k dalyA K Daly,j g reillyJ G Reilly,i n ferrierI N Ferrier,s h l thomasS H L Thomas,

    The objective of this study was to investigate factors affecting steady-state plasma concentrations of thioridazine. A cross-sectional study of patients receiving chronic thioridazine was employed. Common allelic variants of CYP2D6 and CYP2C19, as well as thioridazine and metabolite concentrations and QTc intervals, were determined. In 97 patients, dose-corrected plasma concentrations (C/Ds) of thioridazine and metabolites were correlated with age but not sex or CYP2C19 genotype. Patients with no functional CYP2D6 alleles (n=9) had significantly higher C/D for thioridazine (P=0.017) and the ring sulfoxide metabolite and a significantly higher thioridazine/mesoridazine ratio compared with those with >/=1 functional CYP2D6 allele (n=82). Smokers had significantly lower C/D for thioridazine, mesoridazine, and sulforidazine and significantly lower thioridazine/ring sulfoxide ratios than non-smokers. QTc interval was not significantly affected by CYP2D6 or CYP2C19 genotypes. Plasma concentrations of thioridazine are influenced by age, smoking, and CYP2D6 genotype, but CYP2D6 genotype does not appear to influence on-treatment QTc interval.

    Factors affecting drug concentrations and QT interval during thioridazine therapy. Publishing Authors By Initials

    rh thanacoodyRH Thanacoody,ak dalyAK Daly,jg reillyJG Reilly,in ferrierIN Ferrier,sh thomasSH Thomas,

    For similar genetic phenomena: variation (genetics) research abstracts see: genetic phenomena: variation (genetics) research

    PUBMED ID PMID:

    MEDLINE DATE:

    Factors affecting drug concentrations and QT interval during thioridazine therapy. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Clinical pharmacology and therapeutics

    VOLUME: 82

    Page Numbers: 555-65

    Journal Abbreviation: Clin. Pharmacol. Ther.

    ISSN: 1532-6535

    DAY: 25

    MONTH: 04

    YEAR: 2007

    Factors affecting drug concentrations and QT interval during thioridazine therapy. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 372741

    Factors affecting drug concentrations and QT interval during thioridazine therapy. Keywords Mesh Terms:

    KEYWORDS: Variation (Genetics)

    MESH TERMS: pharmacokinetics

    Chemical & Substance for Abstract: Factors affecting drug concentrations and QT interval during thioridazine therapy. Information

    Substance Name: Cytochrome P-450 CYP2D6

    Registry Number: EC 1.14.14.1

    Grant and Affiliation Information for Factors affecting drug concentrations and QT interval during thioridazine therapy.

    AFFILIATION: School of Clinical and Laboratory Sciences, University of Newcastle, Newcastle upon Tyne, UK.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Clin Pharmacol Ther

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Factors affecting drug concentrations and QT interval during thioridazine therapy Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News